The global Rare Disease Genetic Testing market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Quest Diagnostics
Ambry Genetics
3billion
Centogene
Strand Life Sciences
Invitae Corporation
Macrogen
Eurofins Scientific
Arup Laboratories
Perkin Elmer
Coopersurgical
LabCorp
Baylor Genetics
Fulgent Genetics
Progenity
Color Genomics
Opko Health
Myriad Genetics
Preventiongenetics
By Types:
Next-Generation Sequencing (NGS)
Array Technology
PCR-based Testing
Fluorescence in Situ Hybridization (FISH)
Sanger Sequencing
Karyotyping
Others
By Applications:
Research Laboratories and CROs
Diagnostic Laboratories
Hospitals and Clinics
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Rare Disease Genetic Testing Market Size Analysis from 2022 to 2027
1.5.1 Global Rare Disease Genetic Testing Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Rare Disease Genetic Testing Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Rare Disease Genetic Testing Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Rare Disease Genetic Testing Industry Impact
Chapter 2 Global Rare Disease Genetic Testing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Rare Disease Genetic Testing (Volume and Value) by Type
2.1.1 Global Rare Disease Genetic Testing Consumption and Market Share by Type (2016-2021)
2.1.2 Global Rare Disease Genetic Testing Revenue and Market Share by Type (2016-2021)
2.2 Global Rare Disease Genetic Testing (Volume and Value) by Application
2.2.1 Global Rare Disease Genetic Testing Consumption and Market Share by Application (2016-2021)
2.2.2 Global Rare Disease Genetic Testing Revenue and Market Share by Application (2016-2021)
2.3 Global Rare Disease Genetic Testing (Volume and Value) by Regions
2.3.1 Global Rare Disease Genetic Testing Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Rare Disease Genetic Testing Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Rare Disease Genetic Testing Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Rare Disease Genetic Testing Consumption by Regions (2016-2021)
4.2 North America Rare Disease Genetic Testing Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Rare Disease Genetic Testing Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Rare Disease Genetic Testing Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Rare Disease Genetic Testing Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Rare Disease Genetic Testing Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Rare Disease Genetic Testing Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Rare Disease Genetic Testing Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Rare Disease Genetic Testing Sales, Consumption, Export, Import (2016-2021)
4.10 South America Rare Disease Genetic Testing Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Rare Disease Genetic Testing Market Analysis
5.1 North America Rare Disease Genetic Testing Consumption and Value Analysis
5.1.1 North America Rare Disease Genetic Testing Market Under COVID-19
5.2 North America Rare Disease Genetic Testing Consumption Volume by Types
5.3 North America Rare Disease Genetic Testing Consumption Structure by Application
5.4 North America Rare Disease Genetic Testing Consumption by Top Countries
5.4.1 United States Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
5.4.2 Canada Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
5.4.3 Mexico Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
Chapter 6 East Asia Rare Disease Genetic Testing Market Analysis
6.1 East Asia Rare Disease Genetic Testing Consumption and Value Analysis
6.1.1 East Asia Rare Disease Genetic Testing Market Under COVID-19
6.2 East Asia Rare Disease Genetic Testing Consumption Volume by Types
6.3 East Asia Rare Disease Genetic Testing Consumption Structure by Application
6.4 East Asia Rare Disease Genetic Testing Consumption by Top Countries
6.4.1 China Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
6.4.2 Japan Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
6.4.3 South Korea Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
Chapter 7 Europe Rare Disease Genetic Testing Market Analysis
7.1 Europe Rare Disease Genetic Testing Consumption and Value Analysis
7.1.1 Europe Rare Disease Genetic Testing Market Under COVID-19
7.2 Europe Rare Disease Genetic Testing Consumption Volume by Types
7.3 Europe Rare Disease Genetic Testing Consumption Structure by Application
7.4 Europe Rare Disease Genetic Testing Consumption by Top Countries
7.4.1 Germany Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
7.4.2 UK Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
7.4.3 France Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
7.4.4 Italy Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
7.4.5 Russia Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
7.4.6 Spain Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
7.4.7 Netherlands Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
7.4.8 Switzerland Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
7.4.9 Poland Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
Chapter 8 South Asia Rare Disease Genetic Testing Market Analysis
8.1 South Asia Rare Disease Genetic Testing Consumption and Value Analysis
8.1.1 South Asia Rare Disease Genetic Testing Market Under COVID-19
8.2 South Asia Rare Disease Genetic Testing Consumption Volume by Types
8.3 South Asia Rare Disease Genetic Testing Consumption Structure by Application
8.4 South Asia Rare Disease Genetic Testing Consumption by Top Countries
8.4.1 India Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
8.4.2 Pakistan Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Rare Disease Genetic Testing Market Analysis
9.1 Southeast Asia Rare Disease Genetic Testing Consumption and Value Analysis
9.1.1 Southeast Asia Rare Disease Genetic Testing Market Under COVID-19
9.2 Southeast Asia Rare Disease Genetic Testing Consumption Volume by Types
9.3 Southeast Asia Rare Disease Genetic Testing Consumption Structure by Application
9.4 Southeast Asia Rare Disease Genetic Testing Consumption by Top Countries
9.4.1 Indonesia Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
9.4.2 Thailand Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
9.4.3 Singapore Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
9.4.4 Malaysia Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
9.4.5 Philippines Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
9.4.6 Vietnam Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
9.4.7 Myanmar Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
Chapter 10 Middle East Rare Disease Genetic Testing Market Analysis
10.1 Middle East Rare Disease Genetic Testing Consumption and Value Analysis
10.1.1 Middle East Rare Disease Genetic Testing Market Under COVID-19
10.2 Middle East Rare Disease Genetic Testing Consumption Volume by Types
10.3 Middle East Rare Disease Genetic Testing Consumption Structure by Application
10.4 Middle East Rare Disease Genetic Testing Consumption by Top Countries
10.4.1 Turkey Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
10.4.3 Iran Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
10.4.5 Israel Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
10.4.6 Iraq Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
10.4.7 Qatar Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
10.4.8 Kuwait Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
10.4.9 Oman Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
Chapter 11 Africa Rare Disease Genetic Testing Market Analysis
11.1 Africa Rare Disease Genetic Testing Consumption and Value Analysis
11.1.1 Africa Rare Disease Genetic Testing Market Under COVID-19
11.2 Africa Rare Disease Genetic Testing Consumption Volume by Types
11.3 Africa Rare Disease Genetic Testing Consumption Structure by Application
11.4 Africa Rare Disease Genetic Testing Consumption by Top Countries
11.4.1 Nigeria Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
11.4.2 South Africa Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
11.4.3 Egypt Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
11.4.4 Algeria Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
11.4.5 Morocco Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
Chapter 12 Oceania Rare Disease Genetic Testing Market Analysis
12.1 Oceania Rare Disease Genetic Testing Consumption and Value Analysis
12.2 Oceania Rare Disease Genetic Testing Consumption Volume by Types
12.3 Oceania Rare Disease Genetic Testing Consumption Structure by Application
12.4 Oceania Rare Disease Genetic Testing Consumption by Top Countries
12.4.1 Australia Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
12.4.2 New Zealand Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
Chapter 13 South America Rare Disease Genetic Testing Market Analysis
13.1 South America Rare Disease Genetic Testing Consumption and Value Analysis
13.1.1 South America Rare Disease Genetic Testing Market Under COVID-19
13.2 South America Rare Disease Genetic Testing Consumption Volume by Types
13.3 South America Rare Disease Genetic Testing Consumption Structure by Application
13.4 South America Rare Disease Genetic Testing Consumption Volume by Major Countries
13.4.1 Brazil Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
13.4.2 Argentina Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
13.4.3 Columbia Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
13.4.4 Chile Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
13.4.5 Venezuela Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
13.4.6 Peru Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
13.4.8 Ecuador Rare Disease Genetic Testing Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Rare Disease Genetic Testing Business
14.1 Quest Diagnostics
14.1.1 Quest Diagnostics Company Profile
14.1.2 Quest Diagnostics Rare Disease Genetic Testing Product Specification
14.1.3 Quest Diagnostics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Ambry Genetics
14.2.1 Ambry Genetics Company Profile
14.2.2 Ambry Genetics Rare Disease Genetic Testing Product Specification
14.2.3 Ambry Genetics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 3billion
14.3.1 3billion Company Profile
14.3.2 3billion Rare Disease Genetic Testing Product Specification
14.3.3 3billion Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Centogene
14.4.1 Centogene Company Profile
14.4.2 Centogene Rare Disease Genetic Testing Product Specification
14.4.3 Centogene Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Strand Life Sciences
14.5.1 Strand Life Sciences Company Profile
14.5.2 Strand Life Sciences Rare Disease Genetic Testing Product Specification
14.5.3 Strand Life Sciences Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Invitae Corporation
14.6.1 Invitae Corporation Company Profile
14.6.2 Invitae Corporation Rare Disease Genetic Testing Product Specification
14.6.3 Invitae Corporation Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Macrogen
14.7.1 Macrogen Company Profile
14.7.2 Macrogen Rare Disease Genetic Testing Product Specification
14.7.3 Macrogen Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Eurofins Scientific
14.8.1 Eurofins Scientific Company Profile
14.8.2 Eurofins Scientific Rare Disease Genetic Testing Product Specification
14.8.3 Eurofins Scientific Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Arup Laboratories
14.9.1 Arup Laboratories Company Profile
14.9.2 Arup Laboratories Rare Disease Genetic Testing Product Specification
14.9.3 Arup Laboratories Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Perkin Elmer
14.10.1 Perkin Elmer Company Profile
14.10.2 Perkin Elmer Rare Disease Genetic Testing Product Specification
14.10.3 Perkin Elmer Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Coopersurgical
14.11.1 Coopersurgical Company Profile
14.11.2 Coopersurgical Rare Disease Genetic Testing Product Specification
14.11.3 Coopersurgical Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 LabCorp
14.12.1 LabCorp Company Profile
14.12.2 LabCorp Rare Disease Genetic Testing Product Specification
14.12.3 LabCorp Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Baylor Genetics
14.13.1 Baylor Genetics Company Profile
14.13.2 Baylor Genetics Rare Disease Genetic Testing Product Specification
14.13.3 Baylor Genetics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Fulgent Genetics
14.14.1 Fulgent Genetics Company Profile
14.14.2 Fulgent Genetics Rare Disease Genetic Testing Product Specification
14.14.3 Fulgent Genetics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Progenity
14.15.1 Progenity Company Profile
14.15.2 Progenity Rare Disease Genetic Testing Product Specification
14.15.3 Progenity Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Color Genomics
14.16.1 Color Genomics Company Profile
14.16.2 Color Genomics Rare Disease Genetic Testing Product Specification
14.16.3 Color Genomics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Opko Health
14.17.1 Opko Health Company Profile
14.17.2 Opko Health Rare Disease Genetic Testing Product Specification
14.17.3 Opko Health Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Myriad Genetics
14.18.1 Myriad Genetics Company Profile
14.18.2 Myriad Genetics Rare Disease Genetic Testing Product Specification
14.18.3 Myriad Genetics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Preventiongenetics
14.19.1 Preventiongenetics Company Profile
14.19.2 Preventiongenetics Rare Disease Genetic Testing Product Specification
14.19.3 Preventiongenetics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Rare Disease Genetic Testing Market Forecast (2022-2027)
15.1 Global Rare Disease Genetic Testing Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Rare Disease Genetic Testing Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Rare Disease Genetic Testing Value and Growth Rate Forecast (2022-2027)
15.2 Global Rare Disease Genetic Testing Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Rare Disease Genetic Testing Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Rare Disease Genetic Testing Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Rare Disease Genetic Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Rare Disease Genetic Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Rare Disease Genetic Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Rare Disease Genetic Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Rare Disease Genetic Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Rare Disease Genetic Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Rare Disease Genetic Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Rare Disease Genetic Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Rare Disease Genetic Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Rare Disease Genetic Testing Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Rare Disease Genetic Testing Consumption Forecast by Type (2022-2027)
15.3.2 Global Rare Disease Genetic Testing Revenue Forecast by Type (2022-2027)
15.3.3 Global Rare Disease Genetic Testing Price Forecast by Type (2022-2027)
15.4 Global Rare Disease Genetic Testing Consumption Volume Forecast by Application (2022-2027)
15.5 Rare Disease Genetic Testing Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Request Sample 
Request Discount 
Inquire Before Buy
